Danaher Corporation (VIE:DHRC)

Market Cap	128.72B
Revenue (ttm)	20.50B
Net Income (ttm)	2.91B
Shares Out	n/a
EPS (ttm)	4.02
PE Ratio	44.19
Forward PE	25.60
Dividend	1.10 (0.61%)
Ex-Dividend Date	Sep 26, 2025

Volume	n/a
Average Volume	1
Open	179.76
Previous Close	181.16
Day's Range	179.76 - 184.04
52-Week Range	153.52 - 258.45
Beta	n/a
RSI	67.22
Earnings Date	Oct 21, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DHRC

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD